List of Studies ( Metabolite:Sulfuric acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004200 | AN006985 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004200 | AN006986 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST003533 | AN005804 | Nutrient intervention protects against retinal dysfunction from disrupted peroxisomal fatty acid oxidation | Eye tissue | Mouse | Eye disease | Boston Children's Hospital | LC-MS |
| ST003089 | AN005053 | Metabolome changes in embryonic CSF (Part 11) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Blood | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Liver | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003087 | AN005049 | Metabolome changes in embryonic CSF (Part 9) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003086 | AN005047 | Metabolome changes in embryonic CSF (Part 8) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003085 | AN005045 | Metabolome changes in embryonic CSF (Part 7) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003084 | AN005043 | Metabolic changes in embryonic CSF (Part 6) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003002 | AN004930 | The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) | Feces | Human | Sarcopenia | Chinese University of Hong Kong | GC-MS/LC-MS |
| ST003002 | AN004931 | The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) | Feces | Human | Sarcopenia | Chinese University of Hong Kong | GC-MS/LC-MS |
| ST002761 | AN004488 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | LC-MS | |
| ST002760 | AN004484 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney | Rat | Medical College of Wisconsin | LC-MS | |
| ST002759 | AN004480 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney | Rat | Medical College of Wisconsin | LC-MS | |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST001658 | AN002706 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Saccharomyces cerevisiae | Cancer | Johns Hopkins University | LC-MS |
| ST000431 | AN000681 | C2C12 stretch cessation models muscle atrophy and anaplerotic changes in metabolism | Muscle | Mouse | University of North Carolina at Chapel Hill | GC-MS |
